<?xml version="1.0" encoding="UTF-8"?>
<ref id="B216-marinedrugs-18-00627">
 <label>216.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hondebrink</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Tan</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Hermans</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>van Kleef</surname>
    <given-names>R.G.D.M.</given-names>
   </name>
   <name>
    <surname>Meulenbelt</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Westerink</surname>
    <given-names>R.H.S.</given-names>
   </name>
  </person-group>
  <article-title>Additive Inhibition of Human A1β2γ2 GABAA Receptors by Mixtures of Commonly Used Drugs of Abuse</article-title>
  <source>Neurotoxicology</source>
  <year>2013</year>
  <volume>35</volume>
  <fpage>23</fpage>
  <lpage>29</lpage>
  <pub-id pub-id-type="doi">10.1016/j.neuro.2012.12.003</pub-id>
  <pub-id pub-id-type="pmid">23266428</pub-id>
 </element-citation>
</ref>
